CARGOCONNECT-NOVEMBER 2020 - Flipbook - Page 41
check out history, to see if the
excursion happened under
our responsibility areas such
as our HUB operations, flight
or outbound stations.
hat are some of the innovative steps Turkish
Airlines is taking here in
the South Asian region,
especially India to better
Tu rk i s h C a r go h a s b e e n
maintaining its activities in
order to realise the best transportation of time and temperature-sensitive pharma and
healthcare products so as to
make its network even more
integrated via Envirotainer
operation requirements by
adding QEP accreditation to
its important Hyderabad and
ow are you coping with
the increased scrutiny
from pharma shippers?
What factors have
allowed Turkish Airlines
to effectively achieve and
maintain its market leading
As an airline and warehouse
operator, Turkish Cargo is
closely following up on technological and infrastructural developments in the global pharmaceuticals market. This way,
Turkish Cargo is aware of the
needs of all stakeholders of the
time-sensitive air cargo sector–
from integrity of the supply
chain to trainings, standards
and regulations, internal and
external audits– resulting in
better business communication.
Turkish Cargo strives to
maintain its success in the
inspections made in definite
periods by world’s leading
ph a r ma produc ers. Wit h
above, it plans to be an airline which regularly renews
itsel f v ia cont i nuous i mprovement activities. Thanks
to the new dedicated pharma
facilit y that is being constructed at the new Istanbul
Airport Mega Hub, Turkish
Cargo aims to be part of one
of the most important transit
pharma hubs between Asia
here has been quite an
operations expansion with
new destinations added
to your network in Asia,
Europe, Far East and South
America. How has been the
response to these additions? Do you see stable or
more demand arising?
Turkish Cargo aims to become
one of the top 5 global air cargo brands in the world and is
committed to carry out sustainable growth in terms of
business processes and flight
network. We have been adapting our activities to the new
market dynamics to meet the
needs of our customers and
sector partners to offer an enhanced overall service and
network coverage. In September, we have added London
(LHR), Bangkok (BKK), Singapore (SIN), Beirut (BEY) destinations to our flight network.
Bucharest (OTP) and Lahore
(LHE) destinations were added to the flight network within the scope of the winter
schedule. Accordingly, Turkish Cargo’s total direct cargo
network has now reached 95
We have experienced a serious increase in
demand for Turkish Cargo pharma product,
designed for pharmaceutical transportation.
We carried more than 30000 tonnes of
pharmaceutical and healthcare goods, and
medical equipment within the first seven
months of 2020.
hat do you think
is learnt from the
COVID-19 crisis we are currently living through?
The pandemic affected the industry, borders were closed
and transportation restrictions were imposed. Nevertheless, air transportation has
been of great importance even
during this period, and Turkish Cargo largely contributed
to the sustainability of the
global supply chain by transporting shipments of food,
equipment as well as shipments for urgent needs to/
from Turkey and the four corners of the world.
During this period, we
have experienced a serious increase in demand for Turkish
Cargo pharma product, designed for pharmaceutical
transportation. As an IATA
CEIV pharma certified air carrier, we offer industrial solutions such as dedicated temperature-controlled storage rooms,
active containers, and thermal
dollies so as to maintain the
cold chain, through our specialised TK Pharma Care Team.
Turkish Cargo carried more
than 30000 tonnes of pharmaceutical and healthcare goods,
and medical equipment within
the first seven months of 2020.
As a global cargo brand, it
is one of our missions to
medical equipment, shipments of food, and we keep
on supporting all relevant
initiatives against the coronavirus pandemic by ensuring
an air bridge via Istanbul.
hat position do you
see for Indian pharma
in the Asian Century?
Indian drug companies are rapidly increasing their presence
in Asia, thanks to the world’s
most populous countries and
growing incomes. Both its size
and the speed of expansion are
attracting much attention.
Nearly 65 per cent of global patents stemmed from Asia between 2015-2017, having derived from the 50 fastest rising
innovation cities in Asia. This
gives an opportunity for Indian
pharma firms to be a part of an
Asia-wide innovation arc.
India is the largest provider of generic drugs globally.
Indian pharmaceuticals sector
supplies over 50% of the global
demand for various vaccines–
40% of the generic demand in
the US, and 25% of all medicines in the UK. At Turkish
Cargo, we are proud to be contributing our part in this sustainable success story.
CargoConnect november 2020 | 41